63629-2612 Medroxyprogesterone Acetate - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

63629-2612

Brand Name:

Medroxyprogesterone Acetate

Generic Name:

Medroxyprogesterone Acetate

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Medroxyprogesterone Acetate

Strength: 10.0

Unit: mg/1

Packages:

Code: 63629-2612-01

Description: 10 TABLET in 1 BOTTLE (63629-2612-1)

Effective Date: Nov. 29, 2022

Discontinued:

Code: 63629-2612-02

Description: 30 TABLET in 1 BOTTLE (63629-2612-2)

Effective Date: Nov. 29, 2022

Discontinued:

Code: 63629-2612-03

Description: 5 TABLET in 1 BOTTLE (63629-2612-3)

Effective Date: Nov. 29, 2022

Discontinued:

Code: 63629-2612-04

Description: 60 TABLET in 1 BOTTLE (63629-2612-4)

Effective Date: Nov. 29, 2022

Discontinued:

Code: 63629-2612-05

Description: 90 TABLET in 1 BOTTLE (63629-2612-5)

Effective Date: Nov. 29, 2022

Discontinued:

Code: 63629-2612-06

Description: 20 TABLET in 1 BOTTLE (63629-2612-6)

Effective Date: Nov. 29, 2022

Discontinued:

Code: 63629-2612-07

Description: 100 TABLET in 1 BOTTLE (63629-2612-7)

Effective Date: Nov. 29, 2022

Discontinued:

SEER*Rx Category:

Hormonal Therapy

Major Class:

Progestin

Minor Class:

Orphan Drug Designation:

Status:

In Use